2022 Pap Smear/HPV Market Assessment--Global, Regional, China, India

Abstract

This new report from LeadingMarketResearch.com presents a detailed analysis of the global Pap Smear/HPV testing market, including test volume and sales forecasts for major geographic regions and countries:

Asia-Pacific
China
Europe
India
Japan
Latin America
Middle East Africa
North America
Rest of World

The report is available by section, and can be customized to specific information needs and budget.

The report also presents the Pap Smear and HPV clinical significance and current laboratory practice; examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

TABLE 1
PAP SMEAR
GLOBAL TEST VOLUME AND DIAGNOSTICS SALES BY REGION 

TABLE 2
HPV
GLOBAL TEST VOLUME AND DIAGNOSTICS SALES BY REGION

TABLE 3
GLOBAL
MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS
ESTIMATED MARKET SHARES

TABLE 4
CHINA
PAP SMEAR
TEST VOLUME AND SALES BY LOCATION

TABLE 5
CHINA
HPV
TEST VOLUME AND SALES BY LOCATION

TABLE 6
CHINA
MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS
ESTIMATED MARKET SHARES

TABLE 7
INDIA
PAP SMEAR
TEST VOLUME AND SALES BY LOCATION

TABLE 8
INDIA
HPV
TEST VOLUME AND SALES BY LOCATION

TABLE 9
INDIA
MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS
ESTIMATED MARKET SHARES

Content
Table of Contents

I. Introduction
II. Worldwide Market and Technology Overview
A. Clinical Significance and Laboratory Practices
B. Diagnostic Testing Instrumentation Review and Market Needs
C. Current and Emerging Diagnostic Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
3. Molecular Diagnostics
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
D. Personal Testing
III. Global, Regional, Country Market Forecasts and Suppliers Shares
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. Competitive Profiles
The report provides strategic assessments of over 30 leading cancer diagnostics market players
and start-up companies with innovative technologies and products, including:
- Abbott
- Affymetrix
- Beckman Coulter/Danaher/Cepheid
- Becton Dickinson
- bioMerieux
- Bio-Rad
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujifilm Wako
- Fujirebio
- Grifols
- Hologic
- Leica Biosystems
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Siemens Healthineers
- Takara Bio
- Thermo Fisher and others.
TABLE 1
PAP SMEAR
GLOBAL TEST VOLUME AND DIAGNOSTICS SALES BY REGION
TABLE 2
HPV
GLOBAL TEST VOLUME AND DIAGNOSTICS SALES BY REGION
TABLE 3
GLOBAL
MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS
ESTIMATED MARKET SHARES
TABLE 4
CHINA
PAP SMEAR
TEST VOLUME AND SALES BY LOCATION
TABLE 5
CHINA
HPV
TEST VOLUME AND SALES BY LOCATION
TABLE 6
CHINA
MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS
ESTIMATED MARKET SHARES
TABLE 7
INDIA
PAP SMEAR
TEST VOLUME AND SALES BY LOCATION
TABLE 8
INDIA
HPV
TEST VOLUME AND SALES BY LOCATION
TABLE 9
INDIA
MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS
ESTIMATED MARKET SHARES